FTC challenges ‘junk’ drug patents. Here’s what they are and why they matter

FTC challenges 'junk' drug patents.  Here's what they are and why they matter

The US Federal Trade Commission (FTC) announced last week that, for the second time, dispute hundreds of rubbish patents listed in the Food and Drug Administrations (FDA) Orange Book, a …

Read more

Study challenges one-size-fits-all approach to vitamin D supplementation guidelines

Study challenges one-size-fits-all approach to vitamin D supplementation guidelines

Credit: Unsplash/CC0 Public Domain A recent study by scientists at Trinity College Dublin sheds light on the complexities of achieving optimal vitamin D status in various populations. Despite substantial research …

Read more